Do analysts recommend ARQ or BLGO?

ARQ presently has a consensus target price of $5.00, suggesting a potential upside of 121.34%. Given ARQ's stronger consensus rating and higher probable upside, analysts plainly believe ARQ is more favorable than BioLargo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ARQ 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, ARQ or BLGO?

BioLargo has lower revenue, but higher earnings than ARQ. BioLargo is trading at a lower price-to-earnings ratio than ARQ, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ARQ $120.34M 0.82 -$52.61M -$1.26 N/A BioLargo $12.23M 2.43 -$3.50M -$0.05 N/A

Is ARQ or BLGO more profitable?

BioLargo has a net margin of -11.45% compared to ARQ's net margin of -42.33%. ARQ's return on equity of -2.54% beat BioLargo's return on equity. Company Net Margins Return on Equity Return on Assets ARQ -42.33% -2.54% -1.88% BioLargo -11.45% -39.90% -22.06%

Do analysts rate BLGO or NTIC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Northern Technologies International 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate BLGO or FSI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Flexible Solutions International 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00

Do analysts recommend AVD or BLGO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts rate BIOX or BLGO?

Bioceres Crop Solutions currently has a consensus target price of $4.00, indicating a potential upside of 845.63%. Given Bioceres Crop Solutions' stronger consensus rating and higher possible upside, research analysts plainly believe Bioceres Crop Solutions is more favorable than BioLargo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioceres Crop Solutions 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

BioLargo (BLGO) Competitors

$0.09 +0.00 (+2.74%)

As of 12:13 PM Eastern

Compare

BLGO vs. ARQ, NTIC, FSI, AVD, and BIOX

Should you buy BioLargo stock or one of its competitors? BioLargo's main competitors and comparable companies include ARQ (ARQ), Northern Technologies International (NTIC), Flexible Solutions International (FSI), American Vanguard (AVD), and Bioceres Crop Solutions (BIOX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "chemicals" industry.

How does BioLargo compare to ARQ?

ARQ (NASDAQ:ARQ) and BioLargo (NASDAQ:BLGO) are both small-cap materials companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

In the previous week, ARQ had 1 more articles in the media than BioLargo. MarketBeat recorded 1 mentions for ARQ and 0 mentions for BioLargo. ARQ's average media sentiment score of 1.79 beat BioLargo's score of 0.32 indicating that ARQ is being referred to more favorably in the media.

Company	Overall Sentiment
ARQ	Very Positive
BioLargo	Neutral

ARQ has a beta of 2.05, suggesting that its share price is 105% more volatile than the broader market. Comparatively, BioLargo has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market.

BioLargo has a net margin of -11.45% compared to ARQ's net margin of -42.33%. ARQ's return on equity of -2.54% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ARQ	-42.33%	-2.54%	-1.88%
BioLargo	-11.45%	-39.90%	-22.06%

18.5% of ARQ shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 20.1% of ARQ shares are held by company insiders. Comparatively, 19.3% of BioLargo shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

ARQ presently has a consensus target price of $5.00, suggesting a potential upside of 121.34%. Given ARQ's stronger consensus rating and higher probable upside, analysts plainly believe ARQ is more favorable than BioLargo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ARQ	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

BioLargo has lower revenue, but higher earnings than ARQ. BioLargo is trading at a lower price-to-earnings ratio than ARQ, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ARQ	$120.34M	0.82	-$52.61M	-$1.26	N/A
BioLargo	$12.23M	2.43	-$3.50M	-$0.05	N/A

Summary

ARQ beats BioLargo on 12 of the 16 factors compared between the two stocks.

How does BioLargo compare to Northern Technologies International?

BioLargo (NASDAQ:BLGO) and Northern Technologies International (NASDAQ:NTIC) are both small-cap materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, BioLargo's average media sentiment score of 0.32 beat Northern Technologies International's score of 0.00 indicating that BioLargo is being referred to more favorably in the media.

Company	Overall Sentiment
BioLargo	Neutral
Northern Technologies International	Neutral

BioLargo has a beta of -0.13, indicating that its stock price is 113% less volatile than the broader market. Comparatively, Northern Technologies International has a beta of 0.18, indicating that its stock price is 82% less volatile than the broader market.

Northern Technologies International has higher revenue and earnings than BioLargo. Northern Technologies International is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLargo	$12.23M	2.43	-$3.50M	-$0.05	N/A
Northern Technologies International	$84.24M	0.90	$20K	-$0.12	N/A

0.0% of BioLargo shares are held by institutional investors. Comparatively, 32.9% of Northern Technologies International shares are held by institutional investors. 19.3% of BioLargo shares are held by insiders. Comparatively, 24.9% of Northern Technologies International shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Northern Technologies International has a net margin of -1.26% compared to BioLargo's net margin of -11.45%. Northern Technologies International's return on equity of -0.45% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLargo	-11.45%	-39.90%	-22.06%
Northern Technologies International	-1.26%	-0.45%	-0.33%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Northern Technologies International	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Northern Technologies International beats BioLargo on 9 of the 13 factors compared between the two stocks.

How does BioLargo compare to Flexible Solutions International?

BioLargo (NASDAQ:BLGO) and Flexible Solutions International (NYSE:FSI) are both small-cap materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Flexible Solutions International has higher revenue and earnings than BioLargo. Flexible Solutions International is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLargo	$12.23M	2.43	-$3.50M	-$0.05	N/A
Flexible Solutions International	$35.58M	2.09	$2.78M	-$0.24	N/A

0.0% of BioLargo shares are owned by institutional investors. Comparatively, 54.3% of Flexible Solutions International shares are owned by institutional investors. 19.3% of BioLargo shares are owned by insiders. Comparatively, 35.8% of Flexible Solutions International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, BioLargo's average media sentiment score of 0.32 beat Flexible Solutions International's score of 0.18 indicating that BioLargo is being referred to more favorably in the media.

Company	Overall Sentiment
BioLargo	Neutral
Flexible Solutions International	Neutral

Flexible Solutions International has a net margin of 10.80% compared to BioLargo's net margin of -11.45%. Flexible Solutions International's return on equity of 10.61% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLargo	-11.45%	-39.90%	-22.06%
Flexible Solutions International	10.80%	10.61%	7.32%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Flexible Solutions International	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	3.00

BioLargo has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market. Comparatively, Flexible Solutions International has a beta of 1.7, suggesting that its share price is 70% more volatile than the broader market.

Summary

Flexible Solutions International beats BioLargo on 11 of the 14 factors compared between the two stocks.

How does BioLargo compare to American Vanguard?

American Vanguard (NYSE:AVD) and BioLargo (NASDAQ:BLGO) are both small-cap materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

BioLargo has lower revenue, but higher earnings than American Vanguard. BioLargo is trading at a lower price-to-earnings ratio than American Vanguard, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Vanguard	$515.11M	0.13	-$49.88M	-$1.90	N/A
BioLargo	$12.23M	2.43	-$3.50M	-$0.05	N/A

American Vanguard has a net margin of -10.70% compared to BioLargo's net margin of -11.45%. American Vanguard's return on equity of -9.05% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Vanguard	-10.70%	-9.05%	-2.78%
BioLargo	-11.45%	-39.90%	-22.06%

79.0% of American Vanguard shares are owned by institutional investors. Comparatively, 0.0% of BioLargo shares are owned by institutional investors. 5.6% of American Vanguard shares are owned by insiders. Comparatively, 19.3% of BioLargo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

American Vanguard has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market. Comparatively, BioLargo has a beta of -0.13, suggesting that its stock price is 113% less volatile than the broader market.

In the previous week, American Vanguard had 1 more articles in the media than BioLargo. MarketBeat recorded 1 mentions for American Vanguard and 0 mentions for BioLargo. American Vanguard's average media sentiment score of 1.76 beat BioLargo's score of 0.32 indicating that American Vanguard is being referred to more favorably in the media.

Company	Overall Sentiment
American Vanguard	Very Positive
BioLargo	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

American Vanguard beats BioLargo on 10 of the 14 factors compared between the two stocks.

How does BioLargo compare to Bioceres Crop Solutions?

Bioceres Crop Solutions (NASDAQ:BIOX) and BioLargo (NASDAQ:BLGO) are both small-cap materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Bioceres Crop Solutions has a beta of 0.44, meaning that its stock price is 56% less volatile than the broader market. Comparatively, BioLargo has a beta of -0.13, meaning that its stock price is 113% less volatile than the broader market.

BioLargo has lower revenue, but higher earnings than Bioceres Crop Solutions. BioLargo is trading at a lower price-to-earnings ratio than Bioceres Crop Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioceres Crop Solutions	$293.67M	0.09	-$55.42M	-$3.86	N/A
BioLargo	$12.23M	2.43	-$3.50M	-$0.05	N/A

BioLargo has a net margin of -11.45% compared to Bioceres Crop Solutions' net margin of -92.85%. Bioceres Crop Solutions' return on equity of -33.97% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioceres Crop Solutions	-92.85%	-33.97%	-10.31%
BioLargo	-11.45%	-39.90%	-22.06%

Bioceres Crop Solutions currently has a consensus target price of $4.00, indicating a potential upside of 845.63%. Given Bioceres Crop Solutions' stronger consensus rating and higher possible upside, research analysts plainly believe Bioceres Crop Solutions is more favorable than BioLargo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioceres Crop Solutions	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

17.7% of Bioceres Crop Solutions shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 2.3% of Bioceres Crop Solutions shares are held by insiders. Comparatively, 19.3% of BioLargo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Bioceres Crop Solutions' average media sentiment score of 0.44 beat BioLargo's score of 0.32 indicating that Bioceres Crop Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Bioceres Crop Solutions	Neutral
BioLargo	Neutral

Summary

Bioceres Crop Solutions beats BioLargo on 10 of the 15 factors compared between the two stocks.

Get BioLargo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BLGO vs. The Competition

Export

Metric	BioLargo	Chemicals Industry	Materials Sector	NASDAQ Exchange
Market Cap	$29.71M	$11.58B	$5.08B	$12.87B
Dividend Yield	N/A	2.82%	4.67%	9.14%
P/E Ratio	-9.00	38.78	26.17	25.41
Price / Sales	2.43	57.23	4,866.92	92.36
Price / Cash	N/A	15.18	24.69	35.62
Price / Book	9.00	3.29	10.70	6.43
Net Income	-$3.50M	$222.40M	$158.16M	$358.18M
7 Day Performance	N/A	0.34%	1.84%	1.02%
1 Month Performance	N/A	0.51%	10.04%	-0.47%
1 Year Performance	N/A	17.20%	42.23%	13.80%

BioLargo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BLGO BioLargo	N/A	$0.09 +2.7%	N/A	-60.0%	$29.68M	$12.23M	N/A	30	Gap Up
ARQ ARQ	2.4447 of 5 stars	$2.27 +3.2%	$5.00 +120.3%	-67.5%	$99.13M	$120.34M	N/A	140
NTIC Northern Technologies International	1.6699 of 5 stars	$8.03 +1.6%	N/A	+3.2%	$76.25M	$91.84M	N/A	200
FSI Flexible Solutions International	2.2805 of 5 stars	$5.72 -1.5%	N/A	-39.4%	$73.06M	$35.58M	17.33	40
AVD American Vanguard	1.211 of 5 stars	$2.32 -1.7%	N/A	-58.3%	$68.44M	$510.32M	N/A	800	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BLGO) was last updated on 9/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BioLargo (BLGO) Competitors

BLGO vs. ARQ, NTIC, FSI, AVD, and BIOX

How does BioLargo compare to ARQ?

Summary

How does BioLargo compare to Northern Technologies International?

Summary

How does BioLargo compare to Flexible Solutions International?

Summary

How does BioLargo compare to American Vanguard?

Summary

How does BioLargo compare to Bioceres Crop Solutions?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLGO vs. The Competition

BioLargo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BioLargo (BLGO) Competitors

BLGO vs. ARQ, NTIC, FSI, AVD, and BIOX

How does BioLargo compare to ARQ?

Does the media prefer ARQ or BLGO?

Which has more risk & volatility, ARQ or BLGO?

Is ARQ or BLGO more profitable?

Do insiders and institutionals hold more shares of ARQ or BLGO?

Do analysts recommend ARQ or BLGO?

Which has stronger earnings and valuation, ARQ or BLGO?

Summary

How does BioLargo compare to Northern Technologies International?

Does the media refer more to BLGO or NTIC?

Which has more volatility & risk, BLGO or NTIC?

Which has stronger valuation & earnings, BLGO or NTIC?

Do insiders and institutionals have more ownership in BLGO or NTIC?

Is BLGO or NTIC more profitable?

Do analysts rate BLGO or NTIC?

Summary

How does BioLargo compare to Flexible Solutions International?

Which has better valuation & earnings, BLGO or FSI?

Do insiders & institutionals hold more shares of BLGO or FSI?

Does the media refer more to BLGO or FSI?

Is BLGO or FSI more profitable?

Do analysts rate BLGO or FSI?

Which has more volatility and risk, BLGO or FSI?

Summary

How does BioLargo compare to American Vanguard?

Which has better earnings & valuation, AVD or BLGO?

Is AVD or BLGO more profitable?

Do institutionals and insiders hold more shares of AVD or BLGO?

Which has more volatility and risk, AVD or BLGO?

Does the media prefer AVD or BLGO?

Do analysts recommend AVD or BLGO?

Summary

How does BioLargo compare to Bioceres Crop Solutions?

Which has more volatility & risk, BIOX or BLGO?

Which has preferable valuation and earnings, BIOX or BLGO?

Is BIOX or BLGO more profitable?

Do analysts rate BIOX or BLGO?

Do institutionals and insiders have more ownership in BIOX or BLGO?

Does the media refer more to BIOX or BLGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLGO vs. The Competition

BioLargo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools